InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.9260
-0.0076 (-0.81%)
Feb 26, 2026, 3:10 PM EST - Market open
InflaRx Market Cap
InflaRx has a market cap or net worth of $62.73 million as of February 26, 2026. Its market cap has decreased by -59.02% in one year.
Market Cap
62.73M
Enterprise Value
11.60M
1-Year Change
-59.02%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $62.73M, a decrease of -82.12%. That is a compound annual growth rate of -18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 63.30M | -7.46% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 63.29M |
| Q32 Bio | 62.87M |
| Spruce Biosciences | 62.32M |
| Alterity Therapeutics | 61.47M |
| Instil Bio | 60.77M |
| NRx Pharmaceuticals | 60.08M |
| TScan Therapeutics | 59.59M |
| ImmuCell | 59.34M |